Ghawaa, Y., Ferguson, A., Lin, A., & Guo, J. (2024). EE208 Utilization, Expenditure and Price of Muscular Dystrophy-Duchenne Medications in the US Medicaid Programs: Trends From 2017 to 2022. Value in Health, 27(6), S95. https://doi.org/10.1016/j.jval.2024.03.507
Chicago Style (17th ed.) CitationGhawaa, Y., A. Ferguson, AC Lin, and JJ Guo. "EE208 Utilization, Expenditure and Price of Muscular Dystrophy-Duchenne Medications in the US Medicaid Programs: Trends From 2017 to 2022." Value in Health 27, no. 6 (2024): S95. https://doi.org/10.1016/j.jval.2024.03.507.
MLA (9th ed.) CitationGhawaa, Y., et al. "EE208 Utilization, Expenditure and Price of Muscular Dystrophy-Duchenne Medications in the US Medicaid Programs: Trends From 2017 to 2022." Value in Health, vol. 27, no. 6, 2024, p. S95, https://doi.org/10.1016/j.jval.2024.03.507.